Program Start: 7:30 AM - 9:00 AM Registration Begins 30 minutes prior.
In partnership with the Massachusetts High Tech Council and the New England Venture Capital Association, NACD New England presents a panel discussion on the issues facing growing companies as they move to their "exit"; either a strategic sale or an IPO. One of the first things business advisors to start ups tell Founders is to plan their exits from the start. Whether the company is a roaring success, a lifetime of gradual growth or it flounders, there’s always a time when the survival or growth of the company is contingent on obtaining other sources of capital or when the founder wants to get to warmer climes - permanently. This conversation focuses on the evolution of successful founders through exit, the major inflection points, issues and decisions they face along the way and the implications for boards and corporate governance.
Understand how founders and boards need to change as they face major inflection points in the life of their companies
Highlight how founders needs and expectations of their boards change over time
Identify the similarities and differences in the structure, function, governance and committee structure, roles, direct selection, knowledge diversity, founder needs and expectations of initial boards versus later boards near exit
Discuss to what end these similarities and differences serve in accomplishing business goals
Provide insight into circumstances that lead to one exit strategy over another
Improve the abilities of boards and founders in founder-led companies to capitalize on the strengths of each other to successfully
Dr. Werner Cautreels - President and CEO of Selectra Biosciences - a bio-pharma company
Prior to joining Selecta Biosciences in 2010, Dr. Cautreels was Chief Executive Officer of Solvay Pharmaceuticals, the pharmaceuticals division of the Solvay Group, in Brussels, Belgium, from 2005 until Solvay Pharmaceuticals was acquired by Abbott Laboratories in February 2010. Before becoming the CEO of Solvay Pharmaceuticals, Dr. Cautreels was its Global Head of R&D from 1998.
Prior to joining Solvay, he was employed by Sanofi, Sterling‑Winthrop from 1979 to 1994, and Nycomed‑Amersham from 1994 to 1998 in a variety of R&D management positions in Europe and in the United States. Dr. Cautreels is a director of Galapagos NV in Mechelen, Belgium. He held director positions at Seres Therapeutics, Inc. in Cambridge Massachusetts from January 2013 to July 2016, at Innogenetics NV in Gent, Belgium and at ArQule Inc. in Woburn, Massachusetts each from 1999 to 2006. He was the President of the Belgian‑Luxemburg Chamber of Commerce for Russia and Belarus until June 2010. Dr. Cautreels received his Ph.D. in Chemistry, specializing in Mass Spectrometry, from the University of Antwerp (Antwerp, Belgium), and his financial and business training from the Advanced Management Program at Harvard Business School.
Paul Gudonis - CEO of Myomo – a biomedical devices company
Mr. Gudonis has served as CEO of Myomo for the past five years, positioning the company as the leader in medical robotics to overcome upper extremity paralysis. He has pioneered new technologies and created new markets during his 30-year career spanning biomedical devices, robotics, software, and telecommunications services. From launching the first cellphone service in the country at AT&T to building the first Internet backbone network at BBN into a billion-dollar global services provider, he has grown venture-backed startup companies and led several publicly held corporations.
Myomo, “My Own Motion,” is an MIT spinout that has developed myoelectric orthotics – powered braces controlled by the user’s neurological signals. The company’s innovative devices are restoring movement in the impaired limbs of patients with paralysis due to stroke, spinal cord injury, traumatic brain injury, MS, and ALS. As the first member of his family to go to college, he strongly believes in the value of education, and he worked with noted inventor Dean Kamen for five years to lead the nonprofit robotics competition US FIRST – For Inspiration and Recognition of Science and Technology. During his tenure as President, he oversaw record growth with 200,000 students and 90,000 volunteers in this “sport of the mind,” with the winning teams honored at a White House ceremony.
He has served as a board member of public and private companies, and as Chairman of the Massachusetts High Tech Council. He is a member of the Dean’s Advisory Council at his alma mater, Northwestern University’s McCormick School of Engineering, where he earned his degree in electrical engineering. At the university, he is member of the Biomedical Engineering Department council and advises a student-led startup, Design for America, which is expanding to college campuses nationwide to develop entrepreneurial solutions for local nonprofits . He also earned his MBA degree from Harvard University.
Dave Krupinski - Co-Founder and Chief Technology Officer of Care.com – a technology-based services organization
As Co-Founder and Chief Technology Officer at Care.com, Dave is inspired by the opportunity to leverage technology and the Internet to solve one of the most pressing and important issues that families face today: finding quality care for their loved ones. In his role, Dave oversees all R&D and IT activities of the company, including engineering, quality assurance, reporting, analytics, business intelligence, production operations, infrastructure, and enterprise applications. Dave has more than 25 years of experience in technology leadership roles. Prior to co-founding Care.com, he was Director of Product Management at Upromise from 2000-2006. During his career, Dave has held senior management and executive positions at a number of successful companies including Upromise.com (acquired by Sallie Mae), Direct Hit (acquired by Ask Jeeves) and Stylus Innovation (acquired by Artisoft). He began his career as a Software Engineer at Thomson Financial. Dave serves on the Executive Committee of the Mass Technology Leadership Council (MassTLC), the board of the Massachusetts High Tech Council, the NewCo Boston Advisory Council, and as a co-chair of the Boston Chapter of FWD.us. He is a frequent speaker at industry events. Dave holds a B.A. and M.S. from Boston College and received an M.B.A. from INSEAD in Fontainebleau, France.
Bill Parent - President and CEO of Blue Hills Bank.
William M. Parent is President and Chief Executive Officer of Blue Hills Bank, Blue Hills Bancorp, Inc. and its predecessor company since 2010. Prior to that, Mr. Parent served as a partner and chief investment officer at Grail Partners, a boutique merchant bank. Mr. Parent has over 30 years of experience in the financial services industry, including 16 years at Bank of Boston and its successor companies, FleetBoston and Bank of America, where he held senior executive roles in Finance, Mergers & Acquisitions, Bank Management and Private Equity Investing. Mr. Parent is a non-practicing CPA and holds a BS from Bentley University. He has served as a member of the board of directors for over a dozen middle market companies covering the financial services, retail, distribution and manufacturing sectors. Today, he serves on the board of directors for the YMCA of Greater Boston, Wediko Children Services, Thayer Academy, the Massachusetts Bankers Association and the Savings Banks Employees Retirement Association. He is also a member of the Honor Roll Development Committee for the Campaign for Catholic Schools. Mr. Parent's extensive experience in the financial services industry and his responsibilities for the strategic direction and management of Blue Hills Bank offer the Board an invaluable perspective of the Bank's business and strategic direction.
Lisa Wood - Partner at Foley Hoag
Lisa Wood has more than 30 years of experience handling complex business litigation, principally in the areas of securities fraud, accountants liability and antitrust. She is the Co-Chair of the firm's Litigation Department. Wood also represents companies in federal securities and antitrust litigations and in government investigations by the FTC, Antitrust Division of the Department of Justice and SEC. Wood assists the audit committees of public companies with internal investigations, whistleblower complaints and SEC investigations, and also advises individual public company officers on similar matters. In addition to her active litigation practice, she plays a lead role in firm governance, co-chairing the Litigation Department, and serving on the Distribution and Billing and Intake Committees. She has been instrumental in developing alternative fee arrangements for clients, implementing sophisticated billing and case management systems for complex litigation matters, instilling a client service discipline on case teams and participating in many preferred provider programs with her clients.